Pfizer Inc. today announced detailed results from the Phase 3 HER2CLIMB-05 trial of the tyrosine kinase inhibitor TUKYSA® (tucatinib) as part of an investigational first-line maintenance treatment ...
Everyday Health on MSN
46 gifts for mom that she’ll actually want this holiday season
Is your mom difficult to shop for? We’re here to help. From spa-like luxuries to stress-relieving tools, here are 46 gift ideas for products our editors have tested and loved this year.
I used to think eating healthy meant just loading up on vegetables and calling it a day. But after years of feeling tired despite eating ‘all the right foods,’ I discovered I was missing something ...
Strategic agreement broadens Xanadu’s presence in SingaporeTORONTO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Xanadu Quantum Technologies Inc. (“Xanadu”), a leading photonic quantum computing company, today ...
All those who had the Jacksonville Jaguars as the No. 3 seed in the AFC in early December, please step forward. Stop it -- you're lying if you say you did. The Jaguars have quietly -- and everything ...
Novartis announced new MONALEESA pooled analysis results showing that 25% of HR+/HER2- metastatic breast cancer patients treated first-line with Kisqali plus endocrine therapy remained ...
Siemens and nVent have partnered to create a liquid-cooled reference architecture designed for 100-MW hyperscale AI data-centers, integrating Siemens’ electrical and automation systems with nVent’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results